Bone Growth Products Market Focused Insights 2024-2029: Global Players Medtronic, Johnson & Johnson, Stryker and Zimmer Biomet Lead through Acquisitions, Collaborations and New Product Launches - ResearchAndMarkets.com

The "Bone Growth Products Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.

The Bone Growth Products Market was valued at USD 1.09 billion in 2023, and is expected to reach USD 1.35 billion by 2029, rising at a CAGR of 3.72%.

The global bone growth products market report includes exclusive data on 30 vendors. The market is highly competitive, with global players like Medtronic, Johnson & Johnson, Stryker, and Zimmer Biomet leading through acquisitions, collaborations, and new product launches.

Small and mid-sized companies increasingly enter the market, focusing on novel, cost-effective products. There is a growing emphasis on developing advanced bone healing therapies, such as pulsed electromagnetic field therapies, to address challenges in bone regeneration, especially for elderly and diabetic patients. Key players like Bioventus, Orthofix, and Terumo are enhancing their product portfolios with innovative solutions.

The Rise of Self-Powered Implantable Devices

Invasive bone growth stimulators are implantable devices that supply electrical energy to non-healing fractures or bone fusion sites, aiming to induce bone formation, stimulate growth, and promote healing. These devices, which use direct current delivered via an implanted lead, offer a consistent current to the fracture site, overcoming issues related to patient compliance seen in non-invasive systems. Invasive stimulators are particularly indicated for non-unions of the tibia, femur, and humerus and have proven effective for high-risk individuals undergoing lumbar or sacral fusion, including those with a history of fusion failure or conditions such as smoking, obesity, or diabetes. Bone, being a piezoelectric material, generates a small electrical charge under strain, which aids in healing. The growing advantages of these devices suggest increased adoption in developed countries, with ongoing research to enhance their market presence and efficacy.

Impact of Bone Morphogenetic Proteins (BMPs) in Spinal Fusion and Bone Regeneration

Bone morphogenetic proteins (BMPs), part of the transforming growth factor-beta (TGF-beta) family, have become a promising alternative to autologous bone grafts, especially in spinal fusion and bone regeneration. Approved by the FDA in 2002 for anterior lumbar fusion, BMPs aim to enhance bone healing with fewer complications than traditional grafting methods. They have shown high effectiveness, with fusion rates of 98% compared to 76% for iliac crest grafts (ICBGs), and are used in various spinal fusion techniques, including interbody, posterolateral, and circumferential fusion. BMPs are comparable to ICBGs in safety and efficacy and are expanding into off-label uses, such as posterior spinal fusion and cervical fusion. BMPs, alongside other biological factors like FGF, PDGF, and IGF, play a significant role in advancing bone regeneration. While autologous grafts remain the standard in orthopedic procedures, BMPs offer a well-researched, effective alternative.

The Rising Adoption of Biocompatible Synthetic Bone Grafts and Biologics

The growing use of biocompatible synthetic bone grafts and biologics is a key driver of the bone growth products market. Synthetic grafts, made from materials like ceramics, polymers, and composites, mimic natural bone structure, providing scaffolds for new bone growth while reducing disease transmission and immune rejection risks associated with allografts and autografts. These grafts are especially in demand for spinal fusion surgeries and trauma cases. Biologics, such as bone morphogenetic proteins (BMPs) and platelet-rich plasma (PRP), enhance natural bone healing by promoting cellular activity and bone growth. BMPs induce bone formation, improving outcomes in complex fractures, while PRP accelerates healing. These innovations are transforming the treatment of bone injuries, offering more effective, efficient, and personalized solutions, driving market growth as healthcare providers seek safer, cost-effective options.

Keeping Up with Rapid Technical Advancements

Bone growth stimulators are expensive and often not covered by insurance, leading many to seek affordable alternatives like physiotherapy, Ayurveda, and chiropractic care, especially in developing countries with high out-of-pocket costs. Due to their cost-effectiveness, these alternatives are popular in regions like Japan, China, and India. Additionally, discomfort from bone stimulators and a shortage of orthopedic surgeons drive patients toward traditional treatments. Expanding awareness, improving treatment access, and increasing insurance coverage could boost the adoption of bone growth products in low- and middle-income areas.

GEOGRAPHICAL ANALYSIS

North America accounted for the largest global bone growth products market share, followed by Europe. The U.S. remains a major revenue contributor in North America due to the high penetration of spinal fusion procedures and a considerable volume of spinal fusion and non-fusion surgeries. The increasing prevalence of orthopedic diseases, accidental injuries, and the aging population primarily drive the growth. The availability of advanced, safer, and minimally invasive surgical treatments and ongoing technological innovations further support market expansion.

In Europe, Germany, France, the UK, Italy, and Spain are the primary revenue contributors to the global bone growth products market. This region benefits from a well-established and sophisticated healthcare infrastructure, providing access to advanced medical services, including spinal fusion and non-fusion procedures. The market's growth is driven by the increasing prevalence of bone disorders and the availability of reimbursement coverage for spinal fusion surgeries across many European countries.

COMPETITIVE LANDSCAPE

Key vendors

• Bioventus
• Enovis
• Johnson & Johnson
• Medtronic
• Orthofix
• Stryker
• Zimmer Biomet

Other Prominent Vendors

• Altis Biologics
• Bio-Dynamic Technologies
• BTT Health
• Cellumed
• Elizur
• EmCyte
• Fintek Bio-Electric
• IGEA
• ITO
• Kinex Medical
• Ossatec Benelux
• Pain Rehab Products
• Royal Biologics
• Fujifilm Corp
• Smith & Nephew
• Specialized Orthopedic Solutions
• Stimulate Health
• Terumo
• Globus Medical
• ATEC
• Moximed
• Anika Therapeutics
• Highridge Medical

Key Attributes:

Key Topics Covered:

Chapter 1: Bone Growth Products Market Overview

• Executive Summary
• Key Findings

Chapter 2: Bone Growth Products Market

• Global: Projected Revenue of Bone Growth Products Market (2020-2029; $Millions)

Chapter 3: Bone Growth Products Market Segmentation Data

Global: Projected Revenue by Product (2020-2029; $Millions)

• Bone Growth Stimulator Devices
• Bone Morphogenetic Protein
• Platelet Rich Plasma

Global: Projected Revenue by Application (2020-2029; $Millions)

• Spinal Fusion Surgeries
• Oral & Maxillofacial Surgeries
• Delayed Union & Non-Union Bone Fractures
• Others

Global: Projected Revenue by End-user (2020-2029; $Millions)

• Hospitals & Clinics
• Specialty Orthopedic & Spine Centers
• Ambulatory Surgical Centers

Chapter 4: Key Regions Overview

North America: Projected Revenue of Bone Growth Products Market (2020-2029; $Millions)

• Projected Revenue of Bone Growth Products Market in US
• Projected Revenue of Bone Growth Products Market in Canada

Europe: Projected Revenue of Bone Growth Products Market (2020-2029; $Millions)

• Projected Revenue of Bone Growth Products Market in Germany
• Projected Revenue of Bone Growth Products Market in France
• Projected Revenue of Bone Growth Products Market in UK
• Projected Revenue of Bone Growth Products Market in Italy
• Projected Revenue of Bone Growth Products Market in Spain

APAC: Projected Revenue of Bone Growth Products Market (2020-2029; $Millions)

• Projected Revenue of Bone Growth Products Market in China
• Projected Revenue of Bone Growth Products Market in Japan
• Projected Revenue of Bone Growth Products Market in India
• Projected Revenue of Bone Growth Products Market in Australia
• Projected Revenue of Bone Growth Products Market in South Korea

Latin America: Projected Revenue of Bone Growth Products Market (2020-2029; $Millions)

• Projected Revenue of Bone Growth Products Market in Brazil
• Projected Revenue of Bone Growth Products Market in Mexico
• Projected Revenue of Bone Growth Products Market in Argentina

Middle East & Africa: Projected Revenue of Bone Growth Products Market (2020-2029; $Millions)

• Projected Revenue of Bone Growth Products Market in Turkey
• Projected Revenue of Bone Growth Products Market in Saudi Arabia
• Projected Revenue of Bone Growth Products Market in South Africa

Chapter 5: Bone Growth Products Market Prospects & Opportunities

• Market Opportunities & Trends
• Market Drivers
• Market Constraints

Chapter 6: Bone Growth Products Industry Overview

• Competitive Landscape
• Key Vendor Profiles
• Other Prominent Vendors
• Key Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/26q37u

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241231629109/en/